References
- Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis 1997; 25: 888–895.
- Park CH, Valore EV, Waring AJ, Ganz T, Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806–7810.
- Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program 2006; 29–35: 507.
- Ganz T. Molecular control of iron transport. J Am Soc Nephrol2007; 18: 394–400.
- Ganz T. Iron homeostasis: fitting the puzzle pieces together. CellMetab 2008; 7: 288–290.
- Andrews NC, The iron transporter DMT1. Int J Biochem Cell Biol1999; 31: 991–994.
- Malyszko J, Malyszko JS, Hryszko T, Pawlak K, Mysliwiec M. Ishepcidin a link between anemia, inflammation and liver function in hemodialyzed patients? Am J Nephrol 2005; 25: 586–590.
- Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. Hepcidin, ironstatus, and renal function in chronic renal failure, kidney transplantation, and hemodialysis. Am J Hematology 2006; 81: 832–837.
- Oguz A, Uzunlulu M, Hekim N. Hepcidin is a not marker of chronic inflammation in atherosclerosis. Anadol Kardiyol Derg 2006; 6: 239–242.
- Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease. Transplant Proc 2006; 38: 2895–2898.